United States: Digital Health: Significant FDA Policy Developments In 2022 - Sheppard Mullin Richter & Hampton

In 2022, FDA retreated from a flexible approach to its regulation of digital health in two key areas: (1) its PreCertification Program for software as a medical device (SaMD) and (2) its guidance...